Indication

MET Alteration

1 clinical trial

1 product

Clinical trial

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Status: Recruiting, Estimated PCD: 2026-03-30

Product